Cannabis, which interacts with the body’s natural cannabinoid receptors, could be a viable candidate for pain management and treatment, according to new research published in the journal Experimental and Clinical Psychopharmacology.
The researchers conducted a meta-analysis of previous research that had examined cannabinoid-induced alterations in pain ratings. They identified 25 peer-reviewed studies that met their criteria, which included 2,248 participants in total. The meta-analysis found that cannabinoid administration was associated with greater pain reduction than placebo administration.
Worldwide policies that permit medicinal cannabis use often cite pain conditions as inclusionary criteria. However, despite expanding medicinal cannabis use, the study’s author concludes that further scientific research needs to be undertaken to determine the ‘how’ and ‘why’ cannabinoids alleviate pain.